REATA PHARMACEUTICALS INC-A (RETA) Stock News

NASDAQ:RETA - US75615P1030 - Common Stock

172.36 USD

+0.04 (+0.02%)

Last: 9/25/2023, 8:12:09 PM

172.4 USD

+0.04 (+0.02%)

After Hours: 9/25/2023, 8:12:09 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

RETA Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Kirby McInerney LLP

News Image

Kirby McInerney LLP Announces Pendency of Class Action and Proposed Settlement Involving Purchasers of Reata Pharmaceuticals, Inc. Common Stock

2 years ago - By: Benzinga - Mentions: MRTX FHLC IXJ HART ...

Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024

2 years ago - By: Benzinga - Mentions: GDX GLD BIIB

An Oversold Gold Miner With Strong Fundamentals--Its Relative Strength Index Is Below 20, And Its Piotroski F-Score Is 8

2 years ago - By: Biogen Inc. - Mentions: BIIB

Biogen Completes Acquisition of Reata Pharmaceuticals

2 years ago - By: Seeking Alpha

Reta shareholders clear buyout deal with Biogen (NASDAQ:RETA)

2 years ago - By: Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc.

2 years ago - By: The Motley Fool - Mentions: BIIB

Does Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy?

2 years ago - By: InvestorPlace - Mentions: MNKD JNJ BIIB LLY ...

7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth

2 years ago - By: The Motley Fool - Mentions: BIIB

With an Acquisition on the Way, Is Biogen Stock a Buy?

2 years ago - By: InvestorPlace - Mentions: CABA MLTX FNGR SMCI ...

The 7 Most Promising Momentum Stocks to Own Now

2 years ago - By: InvestorPlace - Mentions: LLY MDGL BIIB HTGC

The 3 Most Promising Pharma Stocks to Own Now

2 years ago - By: Kahn Swick & Foti, LLC

REATA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Reata Pharmaceuticals, Inc. - RETA

2 years ago - By: Brodsky & Smith LLC - Mentions: ESTE FRGI VRTV

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Earthstone Energy, Inc. (NYSE - ESTE), Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), Reata Pharmaceuticals, Inc. (Nasdaq - RETA)

2 years ago - By: Brodsky & Smith LLC - Mentions: FRGI VRTV NEWR BIIB

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA)

2 years ago - By: Seeking Alpha - Mentions: SNY BIIB MRK HZNP ...

Sanofi was mystery bidder in Reata Pharma bidding war - report

2 years ago - By: Bloomberg - Mentions: BIIB

Sanofi Was Mystery Bidder That Lost Reata to Biogen

2 years ago - By: Brodsky & Smith LLC - Mentions: SATS SOVO AMED DISH ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED)

2 years ago - By: Brodsky & Smith LLC - Mentions: FRGI VRTV NEWR BIIB

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fiesta Restaurant Group, Inc. (Nasdaq - FRGI), Veritiv Corporation (NYSE - VRTV), New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA)

2 years ago - By: Kahn Swick & Foti, LLC

REATA PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Reata Pharmaceuticals, Inc. - RETA

2 years ago - By: InvestorPlace - Mentions: REGN BIIB GILD

Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points

2 years ago - By: Brodsky & Smith LLC - Mentions: TALS INPX NEWR BIIB

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: New Relic, Inc. (NYSE - NEWR), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Talaris Therapeutics, Inc. (Nasdaq - TALS), Inpixon® (Nasdaq - INPX)